Cited by 130Intracerebral and Subarachnoid Hemorrhage ResearchDementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments

Cerebral microhemorrhage and brain β-amyloid in aging and Alzheimer disease

Yates, P.A., Sirisriro, R., Villemagne, V.L., Farquharson, S., Masters, C.L., Rowe, C.C., For the AIBL Research Group·2011·Neurology

Abstract

Objectives Incidental cerebral microhemorrhage (MH) is frequently found in older individuals scanned with susceptibility-weighted MRI (SWI) or gradient-recalled echo MRI. MH have been linked with β-amyloid (Aβ) deposition using (11)C-Pittsburgh compound B (PiB) PET in Alzheimer disease (AD) and cerebral amyloid angiopathy (CAA). We hypothesized that Aβ deposition in asymptomatic elderly individuals is associated with lobar MH (LMH). Methods This was a cross-sectional study of 84 elderly healthy controls (HC), 28 subjects with mild cognitive impairment (MCI), and 26 subjects with probable AD who underwent 3-T SWI and (11)C-PiB PET. (11)C-PiB cortical binding was quantified normalized to cerebellar cortex (standardized uptake value ratio [SUVR]) and scans classified as positive (PiB+) or negative (PiB-) by visual inspection. MH were manually counted and categorized by region and as lobar or nonlobar. Results LMH were present in 30.8% of AD, 35.7% of MCI, and 19.1% of HC. The prevalence of LMH among PiB+ subjects was similar, regardless of clinical classification (AD 30.8%, MCI 38.9%, HC 41.4%, p > 0.7). HC with LMH had significantly higher mean neocortical SUVR (1.7 ± 0.5) than HC without LMH (1.3 ± 0.3, p ± 0.01). In HC, there was a positive correlation between number of LMH and SUVR, and between LMH and age. In HC, PiB+ (odds ratio [OR] 7.3, 95% confidence interval [CI] 1.6-33.7, p = 0.01) and age (OR 1.2, 95% CI 1.03-1.3, p = 0.02) both independently predicted the occurrence…

Integrity signals

Registry

Crossref · 10.1212/wnl.0b013e318221ad36

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Both VAβ and hypertensive or atherosclerotic microangiopathy are recognized clinical risk factors for cerebral microbleeds, with VAβ correlating stronger with bleeding in cortical/subcortical distribution and hypertensive/atherosclerotic microangiopathy with bleeding to deep brain structures.

    “Both VAβ and hypertensive or atherosclerotic microangiopathy are recognized clinical risk factors for cerebral microbleeds, with the former correlating stronger with bleeding in cortical/subcortical distribution [58, 59] while the later with bleeding to deep brain structures including basal ganglia and thalamic nuclei [60, 61].”
  • The risk of brain microhemorrhages related to Aβ immunotherapy may be a transient complication and possibly reduced in individuals with modest VAβ burden, who also have lower prevalence of spontaneous microbleeds.

    “Thus, the risk of brain microhemorrhages related to Aβ immunotherapy may be a transient complication and possibly reduced in individuals with modest VAβ burden, who also have lower prevalence of spontaneous microbleeds [58, 59].”

The citation lists haven’t been fetched yet

References 40 · Cited by 130

Authors
Yates, P. A., Sirisriro, R., Villemagne, V. L., Farquharson, S., Masters, C. L., Rowe, C. C., & For the AIBL Research Group
Affiliations
Mental Health Research Institute (AU)
Venue
Neurology
Published
2011-07-05
Volume
77
Issue
1
Pages
48-54
ISSN
  • 0028-3878 (ISSN-L)
  • 1526-632X
OpenAlex
W2168338439
Cited by
130
References
40
Citations by year
2026: 4 · 2025: 6 · 2024: 3 · 2023: 4 · 2022: 4 · 2021: 6 · 2020: 12 · 2019: 5 · 2018: 3 · 2017: 8 · 2016: 11 · 2015: 18 · 2014: 15 · 2013: 11 · 2012: 18
FWCI
9.34
Type
journal article
Language
en
Open access
closed
Locations
  • Neurology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Neurology › Intracerebral and Subarachnoid Hemorrhage Research
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
Keywords
cerebral microhemorrhages, amyloid-beta deposition, Alzheimer's disease, mild cognitive impairment, cerebral amyloid angiopathy, susceptibility-weighted imaging, aging, older adults
MeSH terms
Aged, Aged, 80 and over, Aging, Alzheimer Disease, Aniline Compounds, Brain, Brain Mapping, Carbon Radioisotopes, Cerebral Hemorrhage, Cognition Disorders, Female, Humans, Magnetic Resonance Imaging, Male, Nerve Fibers, Myelinated, Psychiatric Status Rating Scales, Thiazoles, Logistic Models, Amyloid beta-Peptides, Positron-Emission Tomography, Benzothiazoles, Apolipoprotein E4

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review